Navigation Links
Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn
Date:10/8/2007

SANTA MONICA, Calif., Oct. 8 /PRNewswire-USNewswire/ -- Proposed regulations that would govern who owns and controls discoveries resulting from California stem cell research grants to for-profit organizations fail to ensure affordable access to the drugs and cures for California taxpayers paying for the research, the Foundation for Taxpayer and Consumer Rights (FTCR) said today.

"To ensure that the people who have paid for the research to develop these drugs have this affordable access, there must be a provision allowing for intervention by the state attorney general if the drugs are priced unreasonably," wrote John M. Simpson, FTCR Stem Cell Project director, in comments filed with the California Institute for Regenerative Medicine (CIRM).

Read FTCR's comments here: http://www.consumerwatchdog.org/resources/FTCRIPcomment100507.pdf .

The regulations are being reviewed through the state's Office of Administrative Law and will have the full force of law when completed. The most recent proposal was open for public comment and those comments must be considered before the regulations can be implemented.

FTCR also said that a provision in the proposed Intellectual Property (IP) Regulations for For-Profit Organizations that would have tied some stem cell cure prices to the California Prescription Discount Drug Program, (Cal-Rx) was rendered meaningless by Gov. Arnold Schwarzenegger's action on the state budget. In the deal that allowed the state budget to be approved, Schwarzenegger line-item vetoed the money that would have implemented Cal-Rx.

"Clearly, any provisions in the IP policies that intend to implement favorable pricing must rely entirely on the IP regulations under CIRM's auspices and not on some outside scheme that is highly subject to political whim," wrote Simpson.

Simpson wrote that the revised regulations were cleare
'/>"/>

SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Revised Pregnancy Counselling Item Still Flawed
2. Royal College Issues Revised Guidelines for Face Transplantation
3. Government Allot More Funds for Revised TB Program
4. Revised Cholesterol Guidelines Causes Concern Among Medical Community
5. Uttar Pradesh to Declare Revised Medical Entrance Results
6. Passive smoking declared as Toxic in California
7. California Employers may need to Fork out more on Health Benefits
8. An urgent need for prison reforms: California!
9. Death by Smog in California
10. PE Minimums Violations:California Schools Blamed
11. California: Go Ahead For Drug Discount Initiative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...n was linked to coronary artery calcification in s...s) -- Elevated blood levels of phosphorus are asso...esearchers say. , They studied the link between...on (CAC) in nearly 900 healthy adults in the Spoka... disease risk factors. CAC is an early sign of har...
(Date:11/5/2009)... H. Rubenstein, MBBCh, Executive Vice President o...stem, and Dean, School of Medicine, will receive t... to Medical Education from the Association of Amer...esented on Saturday, Nov. 7, during the associatio...ard was established by the AAMC in 1958 to recogni...
(Date:11/5/2009)... Lumenis® Ltd. a global developer, manufact...requency devices for ophthalmic, surgical and aest... of a clinical study into the efficacy of Selectiv...DME). The study will take place at the Tel Aviv Me...of. Anat Loewenstein MD. , ...
(Date:11/5/2009)... FreedomVOICE® proposes telecommuting as a ...rus in the workplace and offers tips to business o... Encinitas, CA (Vocus) -- FreedomV...VoIP PBX , have proposed telecommuting as a viable... the workplace., , ,Whether we like it or not, the...
(Date:11/5/2009)...5 Cadence Pharmaceutical...any focused on in-licensing, developing and commer...ly for use in the hospital setting, today reported...nded September 30, 2009. ,, Based upon the Prio...ence,s New Drug Application (NDA) for Acetavance(T...
Breaking Medicine News(10 mins):Health News:Phosphorus Levels May Predict Heart Disease 2Health News:Penn's Arthur H. Rubenstein receives Distinguished Service award from AAMC 2Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 2Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 3Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 4Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 5Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 6Health News:FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 2Health News:FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 3Health News:FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 4Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 2Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 3Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 4Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 5Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 6Health News:Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 7
...to insurance tend to have healthier children , ...uality of children,s health care in America varie... to insurance and care and the likelihood of livin...ter health care for all Americans. , According to ...
...hcare system better understand where to focus eff...t offers, CAMBRIDGE, MA, May 28 /PRNewswire/ - rL...lity and safety software that helps organizations ...announced today that Caritas Christi has standardi...
...of doctors,across the country finds that physician...litical process, especially when it comes to healt...ans continues to climb, political,candidates are b...re involved in the political process, according to...
...-Device Market With First-to-Market ...alif., May 28 CLRS Technology today,announced a s...DA clearance,for CLARO, the company,s innovative a...commencement of clinical,studies and receipt of a ...
...Large Cell Carcinoma Histologies Achieved, Impro...A-based Regimen, INDIANAPOLIS, May 28 The type o... may now influence their treatment,regimen and, in...nnounced by Eli Lilly and Company., The 1,725-pat...
... had some hard knocks in,her life, including those...e of her owners. Then, in March, the 400-pound lio...aries, this usually results in euthanasia., (Phot... her five years ago, is near Dr. Anne Chauvet, a,v...
Other Medicine News:Health News:States' Scorecard Finds Big Differences in Kids' Health Care 2Health News:States' Scorecard Finds Big Differences in Kids' Health Care 3Health News:Caritas Christi Standardizes on rL Solutions to Help Deliver Best in Class Healthcare Quality 2Health News:Poll Finds That Physicians Long for Political Action 2Health News:CLRS Technology Accelerates Infrastructure Growth Anticipating FDA Clearance for At-Home IPL Acne Device 2Health News:CLRS Technology Accelerates Infrastructure Growth Anticipating FDA Clearance for At-Home IPL Acne Device 3Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 2Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 3Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 4Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 5Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 6Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 7Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 8Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 9Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 10Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 11Health News:Spinal Surgery and Determination Save Lioness 2
(Date:11/5/2009)...,, SAN DIEGO, Nov. 5 ...medical device company created on Sept. 1 through ...cal products businesses, today reported increases ...he first quarter of its fiscal 2010 and raised its...sed with our strong results during the first quart...
(Date:11/5/2009)...,, AUSTIN, Texas and EXTON, Pa., Nov. 5 /PRNews... medical research management software for the Life...ry of the Tecniplast Group, a leading supporter of...t solution, RFID (Radio Frequency Identification) ... efficiency of the animal census process. ,, ...
(Date:11/5/2009)...,, THOUSAND OAKS, Calif., Nov. 5 /PRNewswire-Fi... that the Phase 3 PRIME "203" trial evaluating Vec...ion with FOLFOX (an oxaliplatin-based chemotherapy...al cancer (mCRC) failed to meet a secondary endpoi... announced that the trial met its primary endpoint...
Breaking Medicine Technology:CareFusion Reports First Quarter Results, Raises Full-Year Outlook 2CareFusion Reports First Quarter Results, Raises Full-Year Outlook 3CareFusion Reports First Quarter Results, Raises Full-Year Outlook 4CareFusion Reports First Quarter Results, Raises Full-Year Outlook 5CareFusion Reports First Quarter Results, Raises Full-Year Outlook 6CareFusion Reports First Quarter Results, Raises Full-Year Outlook 7CareFusion Reports First Quarter Results, Raises Full-Year Outlook 8CareFusion Reports First Quarter Results, Raises Full-Year Outlook 9CareFusion Reports First Quarter Results, Raises Full-Year Outlook 10CareFusion Reports First Quarter Results, Raises Full-Year Outlook 11CareFusion Reports First Quarter Results, Raises Full-Year Outlook 12TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census 2TOPAZ Technologies and Tecniplast USA Launch RFID Mobile Census 3Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 2Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 3Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 4Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 5Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 6Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 7Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer 8Clinton Global Initiative Highlights the Freeplay Foundation as Featured Humanitarian Organization 58100 1Clinton Global Initiative Highlights the Freeplay Foundation as Featured Humanitarian Organization 58100 2Clinton Global Initiative Highlights the Freeplay Foundation as Featured Humanitarian Organization 58100 3Brad O 26apos 3BLeary 3A New Poll 3A Health Care Issues Loom Large for 2010 Elections 58098 1Brad O 26apos 3BLeary 3A New Poll 3A Health Care Issues Loom Large for 2010 Elections 58098 2Brad O 26apos 3BLeary 3A New Poll 3A Health Care Issues Loom Large for 2010 Elections 58098 3IEEE USA President endorses national innovation strategy 10050 1
...tely held,biopharmaceutical company focused on the...ygen transport agents, today announced that an,ind...ecommended the,continuation of both Phase III clin...duct, Hemospan(R), under current protocols., This...he blinded data,from the first two-thirds of the 8...
...haromyces boulardii Product from Biocode...BRUNO, Calif., March 11 After undergoing intensiv...-selling probiotic,supplement, has been named to t...b.com, the leading provider of independent test re...care professionals evaluate health,wellness and nu...
Other Medicine Technology:Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review 2Florastor(R) Receives ConsumerLab.com Certification 2Florastor(R) Receives ConsumerLab.com Certification 3
SimonDermatome
Hand Surgery Basic Set (flat handle)
Forceps Round Handle, Str
Needle Holder Delicate, Cvd w/o lock
Medicine Products: